CN104189402A - 治疗崩漏的中药制剂 - Google Patents
治疗崩漏的中药制剂 Download PDFInfo
- Publication number
- CN104189402A CN104189402A CN201410488068.9A CN201410488068A CN104189402A CN 104189402 A CN104189402 A CN 104189402A CN 201410488068 A CN201410488068 A CN 201410488068A CN 104189402 A CN104189402 A CN 104189402A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine preparation
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 206010046788 Uterine haemorrhage Diseases 0.000 title abstract 2
- 239000000463 material Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000009636 Huang Qi Substances 0.000 claims abstract description 7
- 108010052008 colla corii asini Proteins 0.000 claims abstract description 7
- 206010027514 Metrorrhagia Diseases 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 13
- 241000756943 Codonopsis Species 0.000 claims description 7
- 244000286838 Eclipta prostrata Species 0.000 claims description 6
- 235000016993 Agrimonia Nutrition 0.000 claims description 5
- 235000005903 Dioscorea Nutrition 0.000 claims description 5
- 241000234273 Dioscorea Species 0.000 claims description 5
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 5
- 235000004879 dioscorea Nutrition 0.000 claims description 5
- 230000033228 biological regulation Effects 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 241001092084 Agrimonia Species 0.000 claims 2
- 239000006187 pill Substances 0.000 abstract description 5
- 244000307697 Agrimonia eupatoria Species 0.000 abstract description 4
- 238000007796 conventional method Methods 0.000 abstract description 4
- 239000000843 powder Substances 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 27
- 230000000694 effects Effects 0.000 description 23
- 210000000952 spleen Anatomy 0.000 description 17
- 210000003734 kidney Anatomy 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 230000023597 hemostasis Effects 0.000 description 8
- 208000034158 bleeding Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- FBMORZZOJSDNRQ-GLQYFDAESA-N Atractylenolide III Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@@]1(O)C2=C(C)C(=O)O1 FBMORZZOJSDNRQ-GLQYFDAESA-N 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- NQGCBDWQKDAGTK-RYZVSIALSA-N Agrimophol Chemical compound CC1=C(OC)C(C(=O)CCC)=C(O)C(C[C@]2(C)C(C(C(=O)[C@H](C)CC)=C(O)C(C)=C2O)=O)=C1O NQGCBDWQKDAGTK-RYZVSIALSA-N 0.000 description 3
- NQGCBDWQKDAGTK-QDXKXIGTSA-N Agrimophol Natural products O=C(CCC)c1c(OC)c(C)c(O)c(C[C@]2(C)C(=O)C(C(=O)[C@H](CC)C)=C(O)C(C)=C2O)c1O NQGCBDWQKDAGTK-QDXKXIGTSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- TYFJTEPDESMEHE-HNNXBMFYSA-N (3s)-6,8-dihydroxy-3-[2-(4-methoxyphenyl)ethyl]-3,4-dihydroisochromen-1-one Chemical compound C1=CC(OC)=CC=C1CC[C@@H]1OC(=O)C2=C(O)C=C(O)C=C2C1 TYFJTEPDESMEHE-HNNXBMFYSA-N 0.000 description 2
- ALLQLKDRPRORFM-UHFFFAOYSA-N 1-[3,5-bis[[2,6-dihydroxy-4-methoxy-3-methyl-5-(2-methylpropanoyl)phenyl]methyl]-2,4,6-trihydroxyphenyl]-2-methylbutan-1-one Chemical compound CCC(C)C(=O)c1c(O)c(Cc2c(O)c(C)c(OC)c(C(=O)C(C)C)c2O)c(O)c(Cc2c(O)c(C)c(OC)c(C(=O)C(C)C)c2O)c1O ALLQLKDRPRORFM-UHFFFAOYSA-N 0.000 description 2
- SYTGUXGLBXTALU-UHFFFAOYSA-N 2h-1,4-oxazine-3-carboxylic acid Chemical compound OC(=O)C1=NC=COC1 SYTGUXGLBXTALU-UHFFFAOYSA-N 0.000 description 2
- NESFDGDRYVANBC-UHFFFAOYSA-N 6-(hydroxymethyl)pyridin-3-ol Chemical compound OCC1=CC=C(O)C=N1 NESFDGDRYVANBC-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- FBMORZZOJSDNRQ-UHFFFAOYSA-N Demethoxy,B,HCl-Adriamycin Natural products C1C2C(=C)CCCC2(C)CC2(O)C1=C(C)C(=O)O2 FBMORZZOJSDNRQ-UHFFFAOYSA-N 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010029216 Nervousness Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- TYFJTEPDESMEHE-UHFFFAOYSA-N agrimonolide Natural products C1=CC(OC)=CC=C1CCC1OC(=O)C2=C(O)C=C(O)C=C2C1 TYFJTEPDESMEHE-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 208000013433 lightheadedness Diseases 0.000 description 2
- PEFNSGRTCBGNAN-QNDFHXLGSA-N luteolin 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-QNDFHXLGSA-N 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- -1 n-butene acyl lactone Chemical class 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 2
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 2
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 2
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- JVAZJLFFSJARQM-RMPHRYRLSA-N (2r,3r,4s,5s,6r)-2-hexoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JVAZJLFFSJARQM-RMPHRYRLSA-N 0.000 description 1
- KWZYZJKCFHXDRE-KCOGEAQUSA-N (3s,6r)-6-[(9r,10s,13r,14r,17r)-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]-3-propan-2-ylheptan-1-ol Chemical compound C1CCC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC[C@@H](CCO)C(C)C)CC[C@H]33)C)C3=CCC21 KWZYZJKCFHXDRE-KCOGEAQUSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- OQYBLUDOOFOBPO-UHFFFAOYSA-N Asterolide Natural products C1C2C(=C)CCCC2(C)CC2C1=C(C)C(=O)O2 OQYBLUDOOFOBPO-UHFFFAOYSA-N 0.000 description 1
- OQYBLUDOOFOBPO-KCQAQPDRSA-N Atractylenolide II Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@H]1C2=C(C)C(=O)O1 OQYBLUDOOFOBPO-KCQAQPDRSA-N 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- SFKSOXSKEWXFFN-YKORFWMPSA-N C(C)C(O)[C@@]1(O)[C@@H](O)[C@H](O)[C@H](O1)CO.C(C)C(O)[C@@]1(O)[C@@H](O)[C@H](O)[C@H](O1)CO Chemical compound C(C)C(O)[C@@]1(O)[C@@H](O)[C@H](O)[C@H](O1)CO.C(C)C(O)[C@@]1(O)[C@@H](O)[C@H](O)[C@H](O1)CO SFKSOXSKEWXFFN-YKORFWMPSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- KVSNMTUIMXZPLU-UHFFFAOYSA-N D:A-friedo-oleanane Natural products CC12CCC3(C)C4CC(C)(C)CCC4(C)CCC3(C)C2CCC2(C)C1CCCC2C KVSNMTUIMXZPLU-UHFFFAOYSA-N 0.000 description 1
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- JUUHNUPNMCGYDT-UHFFFAOYSA-N Friedelin Natural products CC1CC2C(C)(CCC3(C)C4CC(C)(C)CCC4(C)CCC23C)C5CCC(=O)C(C)C15 JUUHNUPNMCGYDT-UHFFFAOYSA-N 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- JVAZJLFFSJARQM-UHFFFAOYSA-N O-n-hexyl beta-D-glucopyranoside Natural products CCCCCCOC1OC(CO)C(O)C(O)C1O JVAZJLFFSJARQM-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- WJHSRFQBVYHKKL-UHFFFAOYSA-N Oroboside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(C=3C=C(O)C(O)=CC=3)=COC2=C1 WJHSRFQBVYHKKL-UHFFFAOYSA-N 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010051788 Sticky skin Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- OQYBLUDOOFOBPO-YDHLFZDLSA-N atractylenolide II Natural products CC1=C2C[C@H]3C(=C)CCC[C@@]3(C)C[C@@H]2OC1=O OQYBLUDOOFOBPO-YDHLFZDLSA-N 0.000 description 1
- OAXKIRPCKWQWOQ-UHFFFAOYSA-N atractylenolide III Natural products CC1=C2CC3C(CCCC3=C)CC2(O)OC1=O OAXKIRPCKWQWOQ-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- OFMXGFHWLZPCFL-SVRPQWSVSA-N friedelin Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3CCC(=O)[C@@H]1C OFMXGFHWLZPCFL-SVRPQWSVSA-N 0.000 description 1
- MFVJCHSUSSRHRH-UHFFFAOYSA-N friedeline Natural products CC1(C)CCC2(C)CCC3C4(C)CCC5C(C)(C)C(=O)CCC5(C)C4CCC3(C)C2C1 MFVJCHSUSSRHRH-UHFFFAOYSA-N 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- KBGKQZVCLWKUDQ-UHFFFAOYSA-N luteolin-glucoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC2=C1C(=O)C=C(C=1C=C(O)C(O)=CC=1)O2 KBGKQZVCLWKUDQ-UHFFFAOYSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- JVAZJLFFSJARQM-YBXAARCKSA-N n-Hexyl-beta-D-glucopyranoside Natural products CCCCCCO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JVAZJLFFSJARQM-YBXAARCKSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229950007908 piconol Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 1
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229930183580 tangshenoside Natural products 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗崩漏的中药制剂,其特征在于,选用的原料药材及重量组分分别是:地榆炭30份、仙鹤草30份、金刚藤15份、女贞子15份、旱莲草20份、生黄芪15份、川续断15份、炙甘草10份、生地黄24份、当归12份、党参15份、山药30份、阿胶15份、何首乌15份。本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂。本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂。例如可以将这些原料药研成粉末混合均匀散剂冲服;可以将这些原料药一起水煎,然后浓缩煎液服用,或者把浓缩煎液浓缩成膏加工成丸剂服用。
Description
技术领域
本发明涉及中药制剂领域,具体涉及一种用于治疗崩漏的中药制剂。具有健脾益气、清热凉血、固冲止血的功效,治疗崩漏疗效确切。
背景技术
崩漏是指妇女非周期性子宫出血,其发病急骤,暴下如注,大量出血者为“崩”;病势缓,出血量少,淋漓不绝者为“漏”。崩与漏虽出血情况不同,但在发病过程中两者常互相转化,如崩血量渐少,可能转化为漏,漏势发展又可能变为崩,故临床多以崩漏并称。青春期和更年期妇女多见。临床以阴道出血为其主要表现。西医的功能性子宫出血,女性生殖器炎症,肿瘤等所出现的阴道出血,皆属崩漏范畴。崩漏是妇女月经病中较为严重复杂的一个症状。崩漏引起的并发症:(1)贫血:崩漏失血过多,就会出现面色苍白、唇色淡白、头晕目眩、精神倦怠、气短无力、心悸怔仲、失眠多梦、脉象细弱等一系列贫血征象。(2)虚脱:崩漏病起,如来势猛,出血量多,崩下不止,常可引起虚脱,出现神昏面白、四肢冰冷、汗出淋漓、气短喘促、脉浮大无根或沉伏不见的危重证候,如不及时抢救则有生命危险。(3)邪毒感染:表现为下腹疼痛拒按,腰痛,带下稠粘,色黄气秽或五色并见,伴有烦躁口渴,小便黄,大便干,舌苔黄腻,脉象细滑等。多因血热、气虚、肝肾阴虚、血瘀、气郁等损及冲任,冲任气虚不摄所致。治崩要以止血为先,以防晕绝虚脱,待血少或血止后,可审因论治,亦即急则治其标,缓则治其本的原则。
发明内容
本发明所述治疗崩漏的中药制剂,具有健脾益气、清热凉血、固冲止血的功效,治疗崩漏疗效确切。
选用的原料药材及重量组分分别是:地榆炭30份、仙鹤草30份、金刚藤15份、女贞子15份、旱莲草20份、生黄芪15份、川续断15份、炙甘草10份、生地黄24份、当归12份、党参15份、山药30份、阿胶15份、何首乌15份。
本发明选取的原料中药材中,其功效和药理作用分别是:地榆炭:[性味归经]苦、酸,凉。归肝、胃、大肠经。[功效]凉血止血,泻火敛疮。地榆酸涩收敛,性凉清热,味苦沉降,直达下焦,治血热妄行之证,专清下焦血热,用于便血、尿血,崩漏诸证。苦凉泻火解毒,酸涩收敛生肌,故治疗痈肿疮毒,尤为烫伤之良药。
仙鹤草:【性味归经】苦、涩,平。归心、肝经。【功用主治】收敛止血,止痢,杀虫。广泛用于各种出血之证,例如:吐血、尿血、便血、崩漏、咯血、衄血,赤白痢疾,劳伤脱力,痈肿,跌打,创伤出血等证。化学成分:含仙鹤草酚(agrimophol)、仙鹤草内酯(agrimonolide),并含木犀草甙(luteoloside)、仙鹤草甲、乙、丙素(agrimonin A,B,C)、赛仙鹤草酚A~E(agrimol A~E),另含鞣质、甾醇、皂甙及挥发油。
金刚藤:性温,味微辛。功用主治:祛风,活血,解毒。治风湿腰腿痛,跌打损伤,瘰疬。
女贞子:性味:甘,苦,平。归经:肝;肾经;功效分类:补益药。功效:补益肝肾,清虚热,强腰膝,明耳目,乌须发。主治:头昏目眩;腰膝酸软;遗精;耳鸣;须发早白,骨蒸潮热。
旱莲草:有收敛、止血、补肝肾之功效【气味】:(草)甘、酸、寒。无毒。【主治】:鳢肠为滋养收敛之药,有收敛止血排脓之功,可治各种吐血,肠出血等症。捣汁涂眉发,能促进毛发生长,内服有乌发、黑发功效。
生黄芪:味甘,微温,具有补气固表,托疮生肌、利水的功效,主治气血虚弱、自汗、久泻脱肛、子宫脱垂、肾炎浮肿、蛋白尿、糖尿病、慢性溃疡等症。临床用来治疗高血压和急慢性肾炎。
川续断:性味归经:苦、辛,微温。归肝,肾经。功能主治:本种根入药,有行血消肿、生肌止痛、续筋接骨、补肝肾、强腰膝、安胎的功效。强筋骨,利关节,止崩漏。用于腰膝酸痛,风湿关节痛,骨折,跌打损伤,先兆流产,崩漏,带下病,遗精,尿频。活血祛瘀。调血脉。
炙甘草:有抑制胃酸分泌过多、抗酸、缓解胃肠平滑肌痉挛、镇咳、祛痰、抗炎,抗过敏作用,甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用;主治:伤寒病后或重病恢复期阴血不足,血不荣心,虚羸少气,心慌心悸,虚烦少眠,大便干涩,舌质略红少苔,脉象结代不整。或肺痿久咳,吐涎沫稀痰,量多,咽燥而渴,或痰中带血,心悸气短,心中温温液液,失眠多汗,脉虚细而数,或偶见结代。
生地黄:味甘、苦,性寒.入心、肝、肾经。【功效】清热生津滋阴,养血。【主治】治阴虚发热,消渴,吐血,衄血,血崩,月经不调,胎动不安,阴伤便秘。清热凉血,养阴,生津;用于热病烦渴、发斑发疹、阴虚内热、吐血、衄血、糖尿病、传染性肝炎。
当归:【化学成分】含基本内酯、正丁烯酰内酯、阿魏酸、烟酸、蔗糖和多种氨基酸,以及倍半萜类化合物等。【性味归经】性温,昧甘、辛。归肝、心、脾经。【功能主治】补血活血,调经止痛,润肠通便。用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
党参:具有补中益气,健脾益肺的功效。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴等。性味归经:性平,味甘、微酸。归脾、肺经。化学成分:党参含三萜类化合物无羁萜(friedelin)、蒲公英萜醇乙酸酯、α-菠甾醇及其葡萄糖甙、△7-豆甾烯醇及其葡萄糖甙、菠甾酮(spinesterone)。另含苍术内酯III(atractylenolide III),苍术内酯II(atractylenolide II),丁香醛(syringaldehyde),丁香甙(syringin),香草酸(vanillic acid),5-羟基-2-吡啶甲醇(5-hydroxy-2-pyridinemethanol)、α-呋喃羧酸(α-furancarboxylic acid)、正己基-葡萄糖甙(n-hexyl-β-D-glucopyranoside)、乙基-α-D-呋喃果糖甙(ethyl-α-D-fructofuranoside),以及烟酸、4种杂多糖及单糖等。尚含党参甙I、党参内酯和党参酸。
山药:有滋养强壮,助消化,敛虚汗,止泻之功效,主治脾虚腹泻、肺虚咳嗽、糖尿病消渴、小便短频、道精、妇女带下及消化不良的慢性肠炎。性味:甘、平、无毒。归经:归脾、肺、肾经。功用:补脾养胃,生津益肺,补肾涩精。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。麸炒山药补脾健胃。用于脾虚食少,泄泻便溏,白带过多。
阿胶:补血滋阴,润燥,止血。用于血虚萎黄,眩晕心悸,心烦不眠,肺燥咳嗽。气微,味微甘。
何首乌:性味:苦甘涩,微温。归经:入肝、肾经。主要功效:养血滋阴;润肠通便;截疟;祛风;解毒。主血虚头昏目眩;心悸;失眠;肝肾阴虚之腰膝酸软;须发早白;耳鸣;遗精;肠燥便秘;久疟体虚;风疹瘙痒;疮痈;瘰疬;痔疮。
以上方所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相须、相使作用显著,具有健脾益气、清热凉血、固冲止血的作用,是治疗崩漏的内服纯中草药组成制剂。
本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂。例如可以将这些原料药研成粉末混合均匀散剂冲服;可以将这些原料药一起水煎,然后浓缩煎液服用,或者把浓缩煎液浓缩成膏加工成丸剂服用;为了使该药物的各原料更好地发挥药效,针对某原料药进行特殊提取,如乙醇提取,这些不能用于限制本发明的保护范围。本发明的活性组分可以加入制备不同剂型时所需的各种常规辅料,如崩解剂、润滑剂、粘合剂等以常规的中药制剂方法制备成任何一种常用口服剂型,如丸剂、散剂、片剂、胶囊剂、口服液等。
本发明所述药物具有健脾益气、清热凉血、固冲止血的功效,用于治疗崩漏。本发明人经过反复研究,并通过临床试验的反复验证,终于找到了有更好疗效的内服药物,从而完成了本发明。临床应用是有良好的确切效果:
临床应用的基本资料及典型病例:
实施例1.许XX,女,21岁。2012年7月10日初诊。
患者于16岁月经初潮每月定时,量中等,持续7日。从2011年12月开始,月经无定期,每遇劳累或用冷水后即来潮,持续10余天。初期量少、色淡,继而血流如崩,伴有头晕、心慌、冷汗出,全身乏力。前来就诊,诊断为崩漏。患者面色无华,腰酸腿软,苏日带下量多,食欲缺乏。舌质淡、苔薄白,脉沉迟无力。此属脾肾虚,冲任不固,宜健脾补肾,又固冲任。服本方15剂后,自觉全身症状好转,本次月经来潮量中等,持续6日。继续服用本方15剂后,来经规律,量、色和持续时间恢复正常。
方法和有效量:地榆炭30份、仙鹤草30份、金刚藤15份、女贞子15份、旱莲草20份、生黄芪15份、川续断15份、炙甘草10份、生地黄24份、当归12份、党参15份、山药30份、阿胶15份、何首乌15份;取处方规定量中药材饮片,置适宜煎煮器中,加入清水适量,浸泡适宜时间,加热至沸,保持微沸状态一定时间(约25~30分钟),分离煎出液,药渣再加水适量煎煮,按规定煎煮2~3次后,合并煎出液,过滤或沉降分离煎出液供使用。
汤剂内服为主,每日早晚2次内服,每次150ml温服。汤剂则作用快而力峻,适应于病情较急重者。如病情较轻或缓者,宜为丸剂内服求其功。
具体实施方式
治疗崩漏的中药制剂,选用的原料药材及重量组分分别是:地榆炭30份、仙鹤草30份、金刚藤15份、女贞子15份、旱莲草20份、生黄芪15份、川续断15份、炙甘草10份、生地黄24份、当归12份、党参15份、山药30份、阿胶15份、何首乌15份。
本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂。例如可以将这些原料药研成粉末混合均匀散剂冲服;可以将这些原料药一起水煎,然后浓缩煎液服用,或者把浓缩煎液浓缩成膏加工成丸剂服用。
Claims (1)
1.一种治疗崩漏的中药制剂,其特征在于,选用的原料药材及重量组分分别是:地榆炭30份、仙鹤草30份、金刚藤15份、女贞子15份、旱莲草20份、生黄芪15份、川续断15份、炙甘草10份、生地黄24份、当归12份、党参15份、山药30份、阿胶15份、何首乌15份;
制备方法:取地榆炭30份、仙鹤草30份、金刚藤15份、女贞子15份、旱莲草20份、生黄芪15份、川续断15份、炙甘草10份、生地黄24份、当归12份、党参15份、山药30份、阿胶15份、何首乌15份;规定量中药材饮片,置适宜煎煮器中,加入清水适量,浸泡适宜时间,加热至沸,保持微沸状态一定时间(约25~30分钟),分离煎出液,药渣再加水适量煎煮,按规定煎煮2~3次后,合并煎出液,过滤或沉降分离煎出液供使用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410488068.9A CN104189402A (zh) | 2014-09-15 | 2014-09-15 | 治疗崩漏的中药制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410488068.9A CN104189402A (zh) | 2014-09-15 | 2014-09-15 | 治疗崩漏的中药制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104189402A true CN104189402A (zh) | 2014-12-10 |
Family
ID=52074874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410488068.9A Pending CN104189402A (zh) | 2014-09-15 | 2014-09-15 | 治疗崩漏的中药制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104189402A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922321A (zh) * | 2015-06-04 | 2015-09-23 | 陈英娣 | 一种用于治疗崩漏的中药 |
| CN106562427A (zh) * | 2015-10-08 | 2017-04-19 | 张宾 | 一种医治崩漏食疗方剂 |
-
2014
- 2014-09-15 CN CN201410488068.9A patent/CN104189402A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922321A (zh) * | 2015-06-04 | 2015-09-23 | 陈英娣 | 一种用于治疗崩漏的中药 |
| CN106562427A (zh) * | 2015-10-08 | 2017-04-19 | 张宾 | 一种医治崩漏食疗方剂 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101502634B (zh) | 一种治疗宫血的中药组合物及其制备方法 | |
| CN104352776A (zh) | 一种治疗月经过少致不孕的中药制剂及其制备方法 | |
| CN105535471A (zh) | 一种用于治疗神经衰弱的丸剂药物及其制备方法 | |
| CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
| CN104043022A (zh) | 一种治疗妇科炎症的中药组合物 | |
| CN104189381A (zh) | 治疗功能性子宫出血的中药制剂 | |
| CN104435326A (zh) | 治疗急性乳腺炎的中药制剂 | |
| CN104173856A (zh) | 一种治疗带下症的中药组合物 | |
| CN102274445A (zh) | 桂枝三棱消瘤丸 | |
| CN104189402A (zh) | 治疗崩漏的中药制剂 | |
| CN105194338A (zh) | 一种治疗宫寒的中药组合物及其制备方法 | |
| CN101317916B (zh) | 一种治疗崩漏的药剂及其制备方法 | |
| CN104398927A (zh) | 治疗膝关节滑膜炎的中药制剂 | |
| CN103877483A (zh) | 一种治疗慢性胃炎的中药及其制备方法 | |
| CN106692814A (zh) | 一种用于治疗骨病的膏药及其制备方法 | |
| CN105055931A (zh) | 治疗慢性阻塞性肺疾病的中药制剂 | |
| CN104306872A (zh) | 一种治疗子宫肌瘤的中药 | |
| CN104547553A (zh) | 一种治疗神经性内分泌紊乱的中药 | |
| CN104274809A (zh) | 一种治疗经期头痛的中药组合物及其制备方法 | |
| CN103816450B (zh) | 一种治疗类风湿性关节炎的中药 | |
| CN101985005A (zh) | 治疗月经不调的中草药 | |
| CN105125860A (zh) | 一种有效治疗骨质疏松的制剂 | |
| CN106139111A (zh) | 一种可有效治疗抑郁症的中药组合物及其制备方法 | |
| CN105148164A (zh) | 一种家畜安胎补气中药 | |
| CN105770374A (zh) | 一种治疗子宫肌瘤的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141210 |